Osteoarthritis

[00:00:00] - [Speaker 0]
Imagine for a second that your knee joint is just, well, a sponge.

[00:00:03] - [Speaker 1]
Oh, I like that analogy.

[00:00:05] - [Speaker 0]
Right. And for years, you have probably been told that every single step you take is just grinding that poor sponge away. Like osteoarthritis is just this inevitable wear and tear of getting older.

[00:00:17] - [Speaker 1]
Which is such a common thing to hear.

[00:00:19] - [Speaker 0]
It really is.

[00:00:20] - [Speaker 1]
But

[00:00:22] - [Speaker 0]
what if we told you that avoiding movement is actually the very thing that is starving your joints to death?

[00:00:27] - [Speaker 1]
It sounds totally backwards, but it is true.

[00:00:30] - [Speaker 0]
Yeah. So welcome to the deep dive. Today we have a very specific mission. We are cutting through this massive and honestly just overwhelming sea of information regarding osteoarthritis.

[00:00:41] - [Speaker 1]
And that is a sea a lot of people are swimming in right now. I mean we are talking about over thirty three million adults in The United States alone. Wow. Yeah. And more than three hundred million people worldwide.

[00:00:53] - [Speaker 1]
When you get this diagnosis, or maybe someone you love gets it, you are just instantly flooded with contradictory advice.

[00:01:00] - [Speaker 0]
Oh, absolutely. From friends, the internet, random articles.

[00:01:03] - [Speaker 1]
Exactly. Even different medical professionals sometimes. So our goal today is to really clear those muddy waters. We want to build a solid evidence based toolkit for you so you can feel genuinely optimistic about your game plan because this condition is highly manageable.

[00:01:22] - [Speaker 0]
It really is. And to build that toolkit, we brought a stack of just heavy hitting sources today.

[00:01:28] - [Speaker 1]
The good stuff.

[00:01:29] - [Speaker 0]
Yeah, the really good stuff. We are pulling from the comprehensive guidelines from the American College of Rheumatology and the Arthritis Foundation. We also have the arthroplasty guidelines from the American Association of Hip and Knee Surgeons.

[00:01:42] - [Speaker 1]
Which are fantastic resources.

[00:01:43] - [Speaker 0]
They really are. And we're also looking at data from the Centers for Disease Control and Prevention. Plus, we're checking out a pipeline report from the Joint Pain Authority from 2026 to see what futuristic treatments are coming down the road.

[00:01:56] - [Speaker 1]
Lots of ground to cover.

[00:01:57] - [Speaker 0]
Definitely. Yeah. But okay let's unpack this right from the start. We have to just completely throw out the phrase wear and tear. Our sources are absolutely adamant about this.

[00:02:05] - [Speaker 0]
Osteoarthritis is not just your body running out of its warranty.

[00:02:08] - [Speaker 1]
Yeah, not at all.

[00:02:09] - [Speaker 0]
It is a dynamic active disease of the entire joint ecosystem.

[00:02:14] - [Speaker 1]
And that is such a vital distinction to make right away. Calling it wear and tear, well it implies your joints just have this strict expiration date. You just have to sit back and accept your fate.

[00:02:24] - [Speaker 0]
Like a car tire or something.

[00:02:25] - [Speaker 1]
Exactly. But in reality, your joint is constantly trying to repair itself. When cartilage starts to break down, your body You get active inflammation in the synovium.

[00:02:35] - [Speaker 0]
In the synovium, that is the lining of the joint, right?

[00:02:37] - [Speaker 1]
Right. It is the protective capsule lining. And your bones actually start remodeling themselves beneath that cartilage. Sometimes they even grow new bone spurs. We call those osteophytes.

[00:02:48] - [Speaker 0]
Oh, I have heard of those. They sound painful.

[00:02:51] - [Speaker 1]
They can be. But they are actually the body making a desperate attempt to steal only as a wobbly joint. It is a very active biological process. It is not just passive wearing away.

[00:03:01] - [Speaker 0]
So it is less like a car tire wearing down and maybe more like a whole cellular neighborhood reacting to some kind of stress.

[00:03:09] - [Speaker 1]
That is a brilliant way to picture it. Yes.

[00:03:11] - [Speaker 0]
And while there is no magic cure right now, I mean, that it is an active neighborhood means we can actually step in and intervene.

[00:03:19] - [Speaker 1]
Precisely. We have specific tools we can use at every single level of that ecosystem.

[00:03:24] - [Speaker 0]
Which brings us to the foundation of those tools. Before we even think about, you know, opening up the medicine cabinet, the guidelines are incredibly clear here. Movement and mindset are where everything begins.

[00:03:35] - [Speaker 1]
They absolutely are.

[00:03:36] - [Speaker 0]
Yeah. They strongly recommend aerobic exercise, strengthening routines and aquatic therapy. They also recommend weight loss.

[00:03:43] - [Speaker 1]
Yeah.

[00:03:43] - [Speaker 0]
But they highlight something called the 5% rule, which I mean, it feels really manageable.

[00:03:49] - [Speaker 1]
It is incredibly encouraging for patients. I see the relief on their faces all the time.

[00:03:53] - [Speaker 0]
I bet.

[00:03:54] - [Speaker 1]
Studies show that losing just 5% of your body weight yields these clinically meaningful, really noticeable improvements in joint pain.

[00:04:02] - [Speaker 0]
So just 5%?

[00:04:03] - [Speaker 1]
Yeah. So, if you weigh two hundred pounds, losing 10 pounds literally changes the physics of how your knees and hips function.

[00:04:11] - [Speaker 0]
That is wild. Just 10 pounds.

[00:04:13] - [Speaker 1]
It is. Because of the mechanics of walking, every single pound you carry translates to about four pounds of pressure on your knees.

[00:04:20] - [Speaker 0]
Wait, really? A one to four ratio?

[00:04:22] - [Speaker 1]
Yes. So losing 10 pounds, that actually takes 40 pounds of pressure off every single step you take.

[00:04:29] - [Speaker 0]
Oh wow. That is a massive difference.

[00:04:31] - [Speaker 1]
It is huge.

[00:04:32] - [Speaker 0]
But you know, I am struggling to square that with a whole exercise recommendation.

[00:04:36] - [Speaker 1]
How so?

[00:04:36] - [Speaker 0]
Well, if my cartilage is already fraying and damaged, wouldn't hitting the treadmill just grind it down even faster? I mean, feels like driving a car on a flat tire. You are just going to ruin the wheel completely.

[00:04:48] - [Speaker 1]
I hear that from patients every single day. It makes total logical sense until we look a bit closer at how the biology of a joint actually works.

[00:04:56] - [Speaker 0]
Okay, I am listening.

[00:04:57] - [Speaker 1]
What is fascinating here is that unlike your skin or your muscles, your cartilage does not have its own blood supply.

[00:05:03] - [Speaker 0]
Wait, no blood supply at all?

[00:05:05] - [Speaker 1]
None. It has zero arteries or veins running through it. It gets all its oxygen and nutrients directly from the synovial fluid inside the joint space.

[00:05:13] - [Speaker 0]
Oh, I see. So it cannot just like heal itself automatically through the bloodstream like Right. A cut on your arm

[00:05:20] - [Speaker 1]
And the only way to get that nutritious fluid into the cartilage is through mechanical pressure.

[00:05:24] - [Speaker 0]
Oh, this goes back to the sponge analogy.

[00:05:27] - [Speaker 1]
Exactly. Think back to that wet sponge analogy from the beginning. Your cartilage is quite literally like a sponge. When you take a step, your body weight squeezes the old waste fluid out of the cartilage sponge.

[00:05:39] - [Speaker 0]
Okay.

[00:05:39] - [Speaker 1]
And then when you lift your leg to take the next step, the sponge expands and it sucks in fresh nutrient rich fluid.

[00:05:46] - [Speaker 0]
That makes so much sense.

[00:05:47] - [Speaker 1]
So if you stop moving entirely, the sponge just dries out. It becomes brittle, and it actually breaks down much faster. Movement is literally how your joint eats.

[00:05:57] - [Speaker 0]
Wow. So moving is feeding the joint. That just completely flips the script on the wear and tear myth.

[00:06:02] - [Speaker 1]
It really does. It is empowering.

[00:06:04] - [Speaker 0]
And I suppose strengthening the muscles around it helps too. Yeah. Like the quadriceps in your thighs. Do they act like a sort of shock absorber?

[00:06:11] - [Speaker 1]
You nailed it. Having strong quadriceps and strong glutes in your hips, that builds a biological suspension system.

[00:06:18] - [Speaker 0]
Those

[00:06:20] - [Speaker 1]
strong muscles catch the impact of your step before that force even reaches the damaged cartilage inside the knee.

[00:06:27] - [Speaker 0]
That is incredible. Now the guidelines also differentiate between types of movement. I noticed that Tai Chi is strongly recommended for knee and hip osteoarthritis.

[00:06:36] - [Speaker 1]
Yes, it is heavily favored.

[00:06:38] - [Speaker 0]
But then yoga and balance training are only conditionally recommended. Why does Tai Chi get the top tier rating over yoga?

[00:06:45] - [Speaker 1]
Well, it mostly comes down to proprioception.

[00:06:47] - [Speaker 0]
Proprioception, what is that?

[00:06:49] - [Speaker 1]
That is just your brain's awareness of where your body is in space, it is your balance and joint awareness, and it also comes down to the quality of the clinical trials.

[00:06:58] - [Speaker 0]
Ah, the data.

[00:06:59] - [Speaker 1]
Right. Tai Chi has been studied extensively, specifically in the arthritis population. The slow, controlled shifting movements build immense physical stability, but they also significantly lower the psychological burden of chronic pain.

[00:07:14] - [Speaker 0]
That is really interesting. And yoga.

[00:07:16] - [Speaker 1]
Yoga is fantastic truly, but the scientific studies are just a bit more varied in their design, so the medical recommendation is conditional based purely on that evidence quality.

[00:07:25] - [Speaker 0]
Okay, that makes sense. And that mental piece you just mentioned, that is huge.

[00:07:30] - [Speaker 1]
It is often overlooked.

[00:07:31] - [Speaker 0]
Yeah, the guidelines actively recommend cognitive behavioral therapy or CBT and self efficacy programs. Dealing with chronic pain is just exhausting.

[00:07:43] - [Speaker 1]
It drains you completely.

[00:07:44] - [Speaker 0]
It completely rewires your nervous system. Yeah. It ruins your sleep, your mood. So treating the mind is just as biological as treating the knee itself.

[00:07:52] - [Speaker 1]
Absolutely. Pain is ultimately a signal processed in the brain, giving patients psychological tools to manage stress and to reframe how they interpret those pain signals. That is a critical part of the toolkit.

[00:08:04] - [Speaker 0]
Okay. So movement keeps the cartilage sponge fed and therapy helps the

[00:08:08] - [Speaker 1]
mind. Right.

[00:08:09] - [Speaker 0]
But let's be real here for a second. When you have bone on bone friction, taking that very first step can just be agonizing.

[00:08:17] - [Speaker 1]
It can be excruciating.

[00:08:18] - [Speaker 0]
Yeah. People are naturally going to reach for a pill before they reach for their walking shoes. So let's look at the medicine cabinet. Because the medical consensus has completely flipped on some really popular stuff over the last few years.

[00:08:30] - [Speaker 1]
It really has. We are seeing a massive paradigm shift in what doctors recommend.

[00:08:35] - [Speaker 0]
Oh for sure.

[00:08:35] - [Speaker 1]
We are moving away from things that sound good in theory to things that actually prove themselves in rigorous data.

[00:08:42] - [Speaker 0]
And the biggest shocker for me here is glucosamine and chondroitin.

[00:08:46] - [Speaker 1]
Ah, yes. The famous joint supplements.

[00:08:50] - [Speaker 0]
For decades, literally everyone and their mother took these daily supplements. But now the 2019 guidelines strongly recommend against them.

[00:08:59] - [Speaker 1]
With one very tiny exception for hand osteoarthritis, yes.

[00:09:03] - [Speaker 0]
Right, but for knees and hips the highest quality trials show they perform no better than a sugar pill. Why do they fail so badly? It seems so counterintuitive.

[00:09:13] - [Speaker 1]
It goes right back to the blood supply biology we just talked about. Glucosamine and chondroitin are indeed the molecular building blocks of cartilage.

[00:09:19] - [Speaker 0]
Okay. So the logic was there.

[00:09:21] - [Speaker 1]
The idea was that if you eat them, your body will absorb them and rebuild the joint. But remember cartilage has no direct blood supply.

[00:09:30] - [Speaker 0]
Right, the sponge thing.

[00:09:31] - [Speaker 1]
Exactly. When you swallow a glucosamine pill it goes into your stomach. Then your highly acidic stomach acid breaks it down. Wow. And then your liver processes whatever is left.

[00:09:42] - [Speaker 1]
By the time it actually enters your bloodstream, the compounds are largely destroyed. Oh, well. And even if they survived that whole journey, they have no highway to actually reach the cartilage deep inside the knee capsule.

[00:09:55] - [Speaker 0]
So it's kind of like trying to mail a package to a house that has no driveway, no roads leading to it, and no mailbox?

[00:10:02] - [Speaker 1]
That is exactly it. The rigorous data just does not support them at all. The clinical philosophy now is entirely different.

[00:10:08] - [Speaker 0]
What is the new approach then?

[00:10:10] - [Speaker 1]
We want to use the lowest effective dose of medication for the shortest possible time, and crucially, we want to apply that medication as close to the physical problem as possible.

[00:10:20] - [Speaker 0]
Which perfectly explains why topical nonsteroidal anti inflammatory drugs or topical NSAIDs are strongly recommended as a first line treatment for knee osteoarthritis.

[00:10:31] - [Speaker 1]
Yes, this is a game changer for a lot of folks.

[00:10:34] - [Speaker 0]
These are just medicated creams or gels you rub directly under the skin right over the joint right?

[00:10:39] - [Speaker 1]
That is right. You get the medication localized exactly where you need it and you completely bypass the stomach and the liver.

[00:10:44] - [Speaker 0]
Because oral anti inflammatories like taking a daily ibuprofen, they are effective, right?

[00:10:49] - [Speaker 1]
They are very effective at reducing pain and inflammation. But, if you take them every day for years, they block certain chemicals called prostaglandins.

[00:10:58] - [Speaker 0]
And those are important.

[00:10:59] - [Speaker 1]
Very. They protect your stomach lining. So, taking oral pills long term puts you at risk for severe systemic side effects.

[00:11:06] - [Speaker 0]
Like bleeding stomach ulcers.

[00:11:08] - [Speaker 1]
Yes, or kidney damage, or even elevated blood pressure. Topical NSAIDs mitigate those risks beautifully because they stay local.

[00:11:16] - [Speaker 0]
I am curious though where regular acetaminophen like Tylenol fits in. It feels like the safest, most common default pain killer we all have in our cupboards.

[00:11:26] - [Speaker 1]
It is very common, yes, but the guidelines only conditionally recommend acetaminophen.

[00:11:30] - [Speaker 0]
Only conditionally.

[00:11:31] - [Speaker 1]
Yeah, safety is very important, obviously, but efficacy matters just as much. When researchers looked at the massive pools of data, the actual noticeable pain relief patients felt from acetaminophen for osteoarthritis was, well, practically zero.

[00:11:46] - [Speaker 0]
Wait, really? Practically zero?

[00:11:48] - [Speaker 1]
Yeah. It might take the edge off a tiny bit for a mild ache, but as a standalone therapy it simply does not have the chemical power to combat true structural joint inflammation.

[00:11:59] - [Speaker 0]
That is so surprising and speaking of power the guidelines are incredibly strict about what to avoid entirely.

[00:12:05] - [Speaker 1]
Yes they draw a very hard line on a few things.

[00:12:08] - [Speaker 0]
Like opioids, specifically non tramadol opioids and osteoporosis drugs called bisphosphonates. They are strongly recommended against.

[00:12:16] - [Speaker 1]
DN: We want to empower our patients and part of that empowerment is actively protecting them from harm. Opioids carry incredibly high risks of dependency, sedation and just severe side effects.

[00:12:26] - [Speaker 0]
Without even fixing the problem.

[00:12:27] - [Speaker 1]
Exactly. They do not offer meaningful long term relief for this specific type of mechanical joint pain. They just mask the alarm system temporarily without doing anything to help the underlying ecosystem.

[00:12:40] - [Speaker 0]
Right. The neighborhood is still on fire. You just turned off the smoke detector.

[00:12:43] - [Speaker 1]
Exactly.

[00:12:44] - [Speaker 0]
So when pills and creams fail to penetrate deep enough, patients naturally turn to injections.

[00:12:50] - [Speaker 1]
It is the next logical step.

[00:12:51] - [Speaker 0]
And looking at our sources, there are a lot of competing options and honestly a fascinating contradiction in the rules that we really need to clear up. Let's start with the classic cortisone shot, which is a corticosteroid.

[00:13:04] - [Speaker 1]
A very familiar tool in orthopedics?

[00:13:06] - [Speaker 0]
It is strongly recommended for short term relief, but the 2026 update warns against using it long term. They explicitly cap it at three or four shots a year per joint. Why the strict limit?

[00:13:18] - [Speaker 1]
Cortisone is essentially a heavy duty fire extinguisher.

[00:13:21] - [Speaker 0]
Okay.

[00:13:22] - [Speaker 1]
If you have a massively swollen, angry, hot knee, a cortisone shot is incredible. It shuts down the severe inflammation very, very quickly.

[00:13:29] - [Speaker 0]
So it puts the fire out?

[00:13:30] - [Speaker 1]
Yes. However, the mechanism behind it has a bit of a dark side. Corticosteroids can actually inhibit the cells in your cartilage from producing new structural proteins.

[00:13:42] - [Speaker 0]
Oh, that sounds bad.

[00:13:43] - [Speaker 1]
It is. Mounting evidence shows that repeated, frequent cortisone injections can actively accelerate the breakdown of the joint tissue over time.

[00:13:51] - [Speaker 0]
Wow, so the treatment could actually speed up the disease if overused?

[00:13:55] - [Speaker 1]
Precisely. You use it as a rare rescue tool. You use it to calm the joint down just enough to get back to your physical therapy.

[00:14:02] - [Speaker 0]
Not as a permanent routine.

[00:14:03] - [Speaker 1]
Right. It is not a routine maintenance strategy.

[00:14:06] - [Speaker 0]
That makes a lot of sense. Now, that brings us to the contradiction I mentioned earlier.

[00:14:10] - [Speaker 1]
Ah, the hyaluronic acid debate.

[00:14:12] - [Speaker 0]
Yes. Let's look at hyaluronic acid gel injections or The 2019 guidelines conditionally or even strongly dismiss injections.

[00:14:22] - [Speaker 1]
But

[00:14:24] - [Speaker 0]
then, the 2026 Joint Pain Authority report says it is a staple of modern treatment with a twenty five year safety record. How can the medical authorities disagree so completely on the exact same injection?

[00:14:36] - [Speaker 1]
This raises an important question about how we evaluate medical evidence. Specifically, how we look at data in a lab how patients actually live their lives.

[00:14:45] - [Speaker 0]
Okay, unpack that for me.

[00:14:46] - [Speaker 1]
The 2019 guideline committee looked purely at isolated, older clinical trials. In a strict academic vacuum, when you compare an injection directly to a placebo injection, the mathematical difference in pain reduction looked very small on paper to the committee.

[00:15:02] - [Speaker 0]
So the spreadsheets were not impressed.

[00:15:04] - [Speaker 1]
Right. But the 2026 report looks at real world context, safety, and biology.

[00:15:10] - [Speaker 0]
And what exactly is the biology there? Because I have always heard described as just being like WD 40 for a rusty hinge, you know, just a simple lubricant to stop the bones from squeaking.

[00:15:21] - [Speaker 1]
That is a very common analogy, but it drastically undersells what actually does.

[00:15:25] - [Speaker 0]
It is more than just grease.

[00:15:27] - [Speaker 1]
Much more. Hyaluronic acid is a complex molecule that naturally exists in your healthy joint fluid. It provides structural cushioning and lubrication, yes, but it also acts as a sophisticated chemical messenger.

[00:15:38] - [Speaker 0]
A messenger. What is it saying?

[00:15:40] - [Speaker 1]
It binds to specific receptors on your joint cells and it actually tells them to decrease their inflammatory output.

[00:15:46] - [Speaker 0]
Oh wow, so it actively talks to the cells.

[00:15:48] - [Speaker 1]
Yes. Furthermore, these gel injections carry zero risk of destroying your cartilage unlike cortisone. In the real world, doctors know that combining therapies works best.

[00:15:58] - [Speaker 0]
Like using multiple tools at once.

[00:16:00] - [Speaker 1]
Exactly. An injection combined with supervised physical therapy often gives a patient a solid six months of relief. Strict guidelines struggle to measure combined therapies in a vacuum, but clinical practice relies on them every single day.

[00:16:15] - [Speaker 0]
It is not just about the math in a vacuum. It is about giving a patient a six month window to walk their dog, play with their grandkids, and do their exercises without wincing.

[00:16:25] - [Speaker 1]
Exactly. Quality of life.

[00:16:27] - [Speaker 0]
I also see platelet rich plasma or PRP mentioned in the 2026 report. It says PRP actually beats for mild to moderate osteoarthritis.

[00:16:36] - [Speaker 1]
PRP is a fascinating biological tool.

[00:16:38] - [Speaker 0]
How does it work?

[00:16:39] - [Speaker 1]
The doctor draws a small amount of your own blood, spins it in a centrifuge machine to isolate your platelets, and then injects those concentrated platelets right back into your knee.

[00:16:50] - [Speaker 0]
Using your own blood to heal your joint?

[00:16:52] - [Speaker 1]
Yes. Platelets are basically your body's first responders. They are packed with healing growth factors. When injected into the joint, they release these chemical signals that command the inflammatory cells to calm down.

[00:17:03] - [Speaker 0]
That is amazing.

[00:17:04] - [Speaker 1]
It is. They actively modify the toxic inflamed environment inside the knee capsule.

[00:17:10] - [Speaker 0]
That sounds like science fiction in the best way possible. What is the catch?

[00:17:13] - [Speaker 1]
Well the catch is almost entirely financial right now.

[00:17:16] - [Speaker 0]
Ah, of course.

[00:17:17] - [Speaker 1]
Because many insurers still consider PRP investigational, it is largely an out of pocket expense for the patient. We are topping ranging from $400 to well over $1,000 per injection.

[00:17:29] - [Speaker 0]
Oh, that is steep.

[00:17:30] - [Speaker 1]
It is, but it is a very valid evidence backed option if you have the resources.

[00:17:35] - [Speaker 0]
Well, since current injections mostly just manage the environment of the joint, we naturally want to look to the horizon. We want to know if science is close to actually reversing the disease.

[00:17:46] - [Speaker 1]
Everyone wants the cure. Right.

[00:17:48] - [Speaker 0]
And our twenty twenty six pipeline report covers stem cells, biologics and gene therapy. Let's tackle stem cells first because the report highly cautions against them. It is a bit of a wild west out there. Yeah, it says no stem cell therapy is currently approved by the Food and Drug Administration for knee osteoarthritis. Yet, there are all these strip mall clinics charging $10,000 for them right now.

[00:18:11] - [Speaker 1]
This is where patients really need to protect themselves. Biological theory of using stem cells to regenerate a brand new layer of pristine cartilage is beautiful.

[00:18:21] - [Speaker 0]
It sounds perfect.

[00:18:22] - [Speaker 1]
It does, but the clinical reality is simply not there yet. These expensive clinics are often operating in a regulatory grey area.

[00:18:29] - [Speaker 0]
What are they actually injecting then?

[00:18:31] - [Speaker 1]
Usually fat or bone marrow derivatives that just have not been proven to regrow cartilage in humans. A realistic timeline for FDA approved insurance covered stem cell therapies that actually regenerate tissue is least five to ten years away.

[00:18:45] - [Speaker 0]
Wow. So it feels like people are paying for a luxury sports car, but getting a bicycle with a really expensive paint job.

[00:18:52] - [Speaker 1]
That is a very apt way to look at it. Please do not drain your retirement savings account for unproven tech when established. Affordable therapies are available today.

[00:19:01] - [Speaker 0]
Okay, what about biologics? The report mentions a drug called Loracivant that targets inflammation at the molecular level and it is supposedly one to three years out.

[00:19:11] - [Speaker 1]
Yes, that is very promising.

[00:19:13] - [Speaker 0]
But then it tells this huge cautionary tale about a drug called Tanezumab. It showed massive promise but was halted entirely because it caused rapid joint destruction in some patients. How does a drug meant to help arthritis end up destroying a joint?

[00:19:26] - [Speaker 1]
The Tanezumab story is a profound lesson in joint biology and it really shows why this disease is so hard to cure.

[00:19:32] - [Speaker 0]
I am intrigued.

[00:19:33] - [Speaker 1]
So Tanezumab was a biologic drug designed to block nerve growth factor which basically meant it turned off the pain signal completely.

[00:19:43] - [Speaker 0]
So no more pain at all?

[00:19:44] - [Speaker 1]
Right. It was incredibly effective at stopping pain. The problem was patients felt so good that they went out and started running and jumping on joints that were still structurally crumbling. Oh no. Yes.

[00:19:56] - [Speaker 1]
Without the protective signal of pain to tell them to rest or alter their stride, they rapidly destroyed their joints. It led to a catastrophic condition known as a Charcot joint.

[00:20:06] - [Speaker 0]
Oh, wow. So pain is actually a necessary governor for the engine.

[00:20:09] - [Speaker 1]
It is a crucial warning system.

[00:20:11] - [Speaker 0]
If you cut the alarm wire but you do not put out the fire, the house still burns down.

[00:20:15] - [Speaker 1]
Precisely. Osteoarthritis is not just one single chemical pathway. It is a whole complex ecosystem. That is why finding a single drug to cure it is just so elusive.

[00:20:25] - [Speaker 0]
So what is the goal right now then?

[00:20:27] - [Speaker 1]
The goal right now is preservation. Gene therapy, which aims to genetically modify your own cells to constantly pump out anti inflammatory proteins, that is incredibly promising.

[00:20:37] - [Speaker 0]
A further out?

[00:20:38] - [Speaker 1]
Yes, it is a solid ten to fifteen years away. So every single year you keep your natural knee functioning with physical therapy and safe injections. That is a year you allow this medical research to mature. You are buying time.

[00:20:51] - [Speaker 0]
Buying time for the science to catch up But like inevitably for some folks, the foundation, the medicine cabinet and the needle, they all fail.

[00:21:00] - [Speaker 1]
It happens.

[00:21:01] - [Speaker 0]
The future tech is not ready and the pain becomes unbearable. This brings us to surgery. The 2023 guidelines from the American College of Rheumatology and the American Association of Hip and Knee Surgeons fundamentally changed the rules for who gets a joint replacement.

[00:21:16] - [Speaker 1]
They absolutely did, and it is a massive compassionate shift in how we approach patient care in orthopedics.

[00:21:21] - [Speaker 0]
The new rule states that if a patient has symptomatic severe osteoarthritis and has failed non operative treatments total knee or hip replacement surgery should not be delayed.

[00:21:31] - [Speaker 1]
That is the new standard.

[00:21:32] - [Speaker 0]
And crucially surgery should not be delayed just to make a patient meet a strict rigid weight loss goal based on their body mass index or BMI.

[00:21:40] - [Speaker 1]
For a long time orthopedic surgeons used very strict BMI cutoffs. Right. If your BMI was above a certain number, the surgeon would literally say, go lose 50 pounds and come back in a year. The logic was that heavier patients have a slightly higher risk of surgical complications.

[00:21:56] - [Speaker 0]
But wait, didn't we just spend the first segment talking about how incredibly important weight loss is for osteoarthritis? Saying, Do not force people to lose weight before surgery feels totally contradictory to the 5% rule we just discussed.

[00:22:11] - [Speaker 1]
It sounds contradictory until you connect this to the bigger picture and look at the human reality.

[00:22:15] - [Speaker 0]
Okay, explain that to me.

[00:22:16] - [Speaker 1]
How is a patient with a bone on bone agonizingly painful knee supposed to exercise and lose 50 pounds?

[00:22:24] - [Speaker 0]
Right, they can't.

[00:22:25] - [Speaker 1]
They cannot walk to the mailbox, let alone hit the gym. The pain just traps them.

[00:22:29] - [Speaker 0]
It is a complete catch 22. You know, you need to lose weight to get the surgery, but you desperately need the surgery to be able to move enough to lose the weight.

[00:22:37] - [Speaker 1]
Exactly. Yeah. These rigid cutoffs were creating massive health They were denying a definitive life changing medical therapy to the exact patients who needed it the most.

[00:22:48] - [Speaker 0]
That is so frustrating.

[00:22:49] - [Speaker 1]
It is. The new guidelines acknowledge that while a high BMI slightly increases surgical risk, denying the surgery ultimately causes far more harm.

[00:22:58] - [Speaker 0]
Because they just keep deteriorating.

[00:23:00] - [Speaker 1]
Right. Without mobility, the patient's cardiovascular health declines, their diabetes worsens, and their overall quality of life just plummets. Getting them a new joint gets them moving again which improves their total systemic health.

[00:23:14] - [Speaker 0]
However, they do draw a firm line at other factors, right? Yeah. The guidelines state surgery should be delayed if the patient has poor blood sugar control measured by an A1C test. Correct. Or if they have high nicotine use, why the difference there?

[00:23:28] - [Speaker 1]
Because uncontrolled blood sugar and active smoking severely impair wound healing.

[00:23:33] - [Speaker 0]
Ah, wound healing.

[00:23:34] - [Speaker 1]
Yes. High sugar in the blood literally feeds bacteria which dramatically increases the risk of infection. And a deep joint infection is a catastrophic complication.

[00:23:43] - [Speaker 0]
That sounds terrifying.

[00:23:44] - [Speaker 1]
It is. You can control blood sugar with medication and you can pause smoking much easier than you can lose 50 pounds on a destroyed knee. It is a very logical evidence based approach to risk.

[00:23:55] - [Speaker 0]
It really is. It is about removing arbitrary barriers and treating the whole patient.

[00:23:59] - [Speaker 1]
Exactly.

[00:24:00] - [Speaker 0]
Well, let's bring this all together. If there is one thing to take away today, it is that your joints are not ticking time bombs. Moving them is actually what feeds them. So keep that cartilage sponge wet.

[00:24:12] - [Speaker 1]
Skip

[00:24:13] - [Speaker 0]
the expensive glucosamine pills that just dissolve in your stomach and look into localized treatments like topical NSAIDs to bypass your liver.

[00:24:21] - [Speaker 1]
And remember to use your injection options strategically. Combine things like hyaluronic acid with physical therapy to buy yourself some time. But, if someone tries to sell you a $10,000 stem cell cure tomorrow, hold onto your wallet.

[00:24:34] - [Speaker 0]
Yeah, keep it in your pocket.

[00:24:36] - [Speaker 1]
Exactly. And finally, if you do need surgery, know your rights regarding rigid BMI cutoffs.

[00:24:42] - [Speaker 0]
Before we wrap up, I want to look at the really big picture. We've talked a lot about the current state of things, but where is the philosophy of treatment actually heading?

[00:24:51] - [Speaker 1]
We currently view osteoarthritis treatment as a ladder.

[00:24:54] - [Speaker 0]
A ladder?

[00:24:55] - [Speaker 1]
Yes. You start on the bottom rung with exercise, you climb step up to injections, and finally at the very top you reach surgery.

[00:25:03] - [Speaker 0]
Right, climbing step by step.

[00:25:05] - [Speaker 1]
But as we learn more about the unique genetic and biomechanical makeup of individual joints, the future of treatment might abandon the latter entirely.

[00:25:14] - [Speaker 0]
Really? What would replace it?

[00:25:16] - [Speaker 1]
Imagine a future where we use an artificial intelligence algorithm instead. An AI could analyze a tiny sample of your specific joint fluid on day one and immediately prescribe a highly personalized cocktail of therapies.

[00:25:29] - [Speaker 0]
Oh, wow.

[00:25:30] - [Speaker 1]
Maybe you specifically need a biologic drug and aquatic therapy while your neighbor needs PRP injections and cognitive behavioral therapy. Personalizing the treatment from day one rather than making everyone climb the same ladder could completely redefine what it means to cure arthritis.

[00:25:47] - [Speaker 0]
I absolutely love that personalized medicine from day one. Well, until that algorithm arrives, remember to keep moving, use your toolkit and do not let the muddy waters keep you from living your life. Thanks for joining us on this deep dive!